Specific Phobias
Marked, irrational fear cued by a specific object or situation, with avoidance and impairment ≥6 months.
Also known as: specific phobia, phobia, simple phobia
Overview
DSM-5-TR: marked fear or anxiety about a specific object or situation (e.g., animals, heights, blood/injection/injury, closed spaces, flying). The phobic stimulus almost always provokes immediate fear, is actively avoided or endured with intense distress, is out of proportion to the actual danger, and persists ≥6 months with significant impairment. Five specifier types: animal, natural environment, blood-injection-injury (BII), situational, other.
Epidemiology
12-month US prevalence ~7-9%; lifetime ~12-15%. Most common anxiety disorder. Female predominance ~2:1 except BII (more equal). Onset typically childhood (median ~7-10 yo); blood-injection-injury and situational often persist into adulthood.
Keep reading — start your free trial
You've read your 2 free diagnosis previews. Create your free account to unlock the full Specific Phobias outline — plus all 514 diagnoses, 5,500+ board-style questions, flashcards, and an AI tutor. Your 7-day free trial includes everything, and there's no credit card required.
Risk factors
- First-degree family history (especially of same phobia subtype)
- Direct traumatic experience or observational learning
- Behavioral inhibition / negative affectivity temperament
- Female sex
- Childhood adversity
Pathophysiology
Conditioned amygdala-driven fear response. Genetic preparedness for evolutionarily salient threats (snakes, heights, blood). BII phobia uniquely associated with a biphasic vasovagal response: initial sympathetic surge followed by parasympathetic-mediated bradycardia and syncope.
Clinical presentation
Symptoms
- Immediate intense fear/anxiety on exposure (or anticipation) of the phobic stimulus
- Active avoidance of the trigger
- Recognition that the fear is excessive (less reliable in children)
- Physiologic symptoms during exposure: tachycardia, sweating, trembling, dyspnea, GI distress
Signs / physical exam
- Sympathetic activation during exposure in most subtypes
- BII subtype: vasovagal response — bradycardia, pallor, hypotension, syncope (often the presenting complaint)
Classic findings
Patient who consistently avoids flying despite job consequences, or faints at sight of blood during routine venipuncture.
Differential diagnosis
- Social anxiety disorder — Fear is specifically of social evaluation, not the object/situation itself
- Panic disorder with agoraphobia — Fear of escape difficulty or incapacitation; multiple situations, not single object
- Obsessive-compulsive disorder — Avoidance driven by obsessions (contamination, harm) rather than direct fear of object
- PTSD — Avoidance linked to a specific past traumatic event with reexperiencing and arousal symptoms
- Separation anxiety disorder — Fear of separation from attachment figures, not of an object
- Realistic fear / cultural belief — Fear proportionate to actual risk or culturally sanctioned
Diagnostic workup
Diagnostic criteria
DSM-5-TR: marked fear of specific object/situation, immediate, avoidance/endurance with distress, out of proportion, ≥6 months, impairment, not better explained by another disorder. Specify subtype.
Labs
- Not routinely needed; clinical diagnosis
Imaging
- Not indicated
Diagnostic algorithm
| Subtype | Examples | Onset | Key feature |
|---|---|---|---|
| Animal | Spiders, dogs, snakes | Childhood | Most common; often co-occurring phobias |
| Natural environment | Heights, storms, water | Childhood | May overlap with situational |
| Blood-injection-injury | Venipuncture, injury, dental | Childhood | Vasovagal syncope; treat with applied tension |
| Situational | Flying, elevators, enclosed spaces | Mid-20s peak | Bimodal onset; high functional impact |
| Other | Choking, vomiting, loud sounds | Variable | Heterogeneous |
Treatment
First-line
- Exposure-based CBT (in vivo, imaginal, or virtual reality) — highly effective; single-session exposure can be curative for many specific phobias
- Graded exposure with response prevention is the gold standard
Second-line / adjunct
- Short-acting benzodiazepine (lorazepam, alprazolam) for one-time situational use (e.g., MRI, flight) — does NOT cure the phobia and may impair learning during exposure
- Beta-blocker before procedure for autonomic blunting
- SSRIs generally not first-line; reserved for comorbid anxiety/depression
Complications
- Avoidance of medical care (BII phobia → unvaccinated, delayed diagnosis, untreated dental disease)
- Occupational restriction (flying phobia, driving phobia)
- Comorbid mood and anxiety disorders
- Substance use to manage anticipatory anxiety
PANCE pearls
- Exposure therapy is more effective than any medication for specific phobia and can be completed in 1-5 sessions for many patients.
- BII phobia is the only phobia with prominent vasovagal syncope — treat with applied tension, not relaxation alone.
- Benzodiazepines used during exposure may blunt the new learning needed for extinction — use sparingly.
- Children may not recognize fear as excessive; reliance on parental report and functional impact is essential.
- Always ask about avoidance of healthcare — BII phobia is a major driver of missed care.
References
- DSM-5-TR — American Psychiatric Association. DSM-5-TR. 2022.
- NICE — National Institute for Health and Care Excellence. Generalised Anxiety Disorder and Panic Disorder in Adults: Management. CG113, 2011 (updated).
- Wolitzky-Taylor 2008 — Wolitzky-Taylor KB et al. Psychological approaches in the treatment of specific phobias: a meta-analysis. Clin Psychol Rev 2008;28(6):1021-37.
Practice Psychiatry/Behavioral questions on FirstPassPA
Turn this outline into retention. 5,500+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Start studying free → Browse all 514 diagnosesEducational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.